TransCon GH
Showing 1 - 25 of 356
Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)
Completed
- Growth Hormone Deficiency, Pediatric
- +3 more
- TransCon hGH
-
Birmingham, Alabama
- +23 more
Dec 7, 2021
Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)
Active, not recruiting
- Growth Hormone Deficiency, Pediatric
- +3 more
- TransCon hGH
-
Birmingham, Alabama
- +41 more
Oct 13, 2021
Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases Trial in Worldwide (Once weekly
Completed
- Growth Hormone Deficiency, Pediatric
- +4 more
- Once weekly subcutaneous injection of TransCon hGH
- Once daily subcutaneous injection of Genotropin
-
Birmingham, Alabama
- +52 more
Dec 6, 2021
Achondroplasia Trial in Parkville (TransCon CNP)
Recruiting
- Achondroplasia
- TransCon CNP
-
Parkville, Victoria, AustraliaAscendis Pharma Investigational Site
Jun 30, 2023
Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)
Not yet recruiting
- Head and Neck Neoplasms
- TransCon TLR7/8 Agonist
- +2 more
- (no location specified)
Aug 4, 2023
Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)
Not yet recruiting
- Achondroplasia
- Navepegritide
- Placebo for Navepegritide
- (no location specified)
Oct 6, 2023
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,
Recruiting
- Advanced Solid Tumor
- +7 more
- TransCon IL-2 β/γ
- +4 more
-
Boston, Massachusetts
- +7 more
Nov 16, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8
Recruiting
- Advanced Solid Tumor
- +6 more
- TransCon TLR7/8 Agonist
- Pembrolizumab
-
Duarte, California
- +12 more
Sep 21, 2022
Achondroplasia Trial in Worldwide (TransCon CNP, Placebo for TransCon CNP, sWfI Placebo for TransCon CNP)
Active, not recruiting
- Achondroplasia
- TransCon CNP
- +2 more
-
Little Rock, Arkansas
- +14 more
Dec 20, 2022
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo
-
San Francisco, California
- +20 more
Aug 5, 2022
Achondroplasia Trial in China (TransCon CNP, Placebo for TransCon CNP)
Recruiting
- Achondroplasia
- TransCon CNP
- Placebo for TransCon CNP
-
Beijing, China
- +5 more
Feb 9, 2022
Discontinuation in Adults on Metabolic Profile, Body Composition
Recruiting
- Adult Growth Hormone Deficiency
- Dual energy X-ray absorptiometry (DXA)
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham NHS Foundation Trust
Jul 28, 2023
miRNA as a Growth Plate Marker After GH
Recruiting
- MicroRNAs: D13.444.735.790.552.500
-
São Paulo, SP, BrazilSanta Casa SP School of Medical Sciences
Jul 7, 2023
Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))
Available
- Hypoparathyroidism
- Palopegteriparatide (TransCon PTH)
- (no location specified)
Jan 10, 2023
Hypoparathyroidism, Parathyroid Hormone Deficiency, Endocrine System Diseases Trial in Beijing (TransCon PTH, )
Recruiting
- Hypoparathyroidism
- +3 more
- TransCon PTH
- placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 18, 2022
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo for TransCon PTH)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo for TransCon PTH
-
Chicago, Illinois
- +14 more
Mar 2, 2022
The AgRP and GH/IGF-1 Axis in Children
Not yet recruiting
- Growth Hormone Deficiency
- (no location specified)
Dec 8, 2022
Therapies in Acromegaly Disease: Acral Morpho-functional Study
Recruiting
- Acromegaly
- Medical surgery therapy
-
Milano, ItalyIstituto Auxologico Italiano IRCCS San Luca
Jul 25, 2023
Turner Syndrome, Short Stature Trial in Washington (Vosoritide)
Not yet recruiting
- Turner Syndrome
- Short Stature
-
Washington, District of ColumbiaChildren's National Hospital
Apr 28, 2023
Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)
Not yet recruiting
- Growth Hormone Deficiency
- Healthy
- growth hormone and lirglutide
- +3 more
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022
Diarrhea Trial in United Kingdom, United States (Florastor®, Travelan®, Placebo)
Recruiting
- Diarrhea
- Travelan®
- Placebo
-
San Diego, California
- +5 more
Feb 1, 2023
Acromegaly Trial in Novara (Usual clinical practice + hypoproteic diet)
Not yet recruiting
- Acromegaly
- Usual clinical practice + hypoproteic diet
-
Novara, Italy: Italy Pediatric Endocrine Service of AOU Maggiore della Carità
Mar 26, 2022
Obesity Trial in Oggebbio (Rehabilitation protocol + guided spontaneous breathing exercises, Rehabilitation protocol + specific
Terminated
- Obesity
- Rehabilitation protocol + guided spontaneous breathing exercises
- Rehabilitation protocol + specific respiratory muscle training program
-
Oggebbio, Verbania, ItalyIstituto Auxologico Italiano, Site Piancavallo
Mar 8, 2023
Liver Cirrhosis, Fibrosis, End Stage Liver Disease Trial in Chandigarh (Growth Hormone)
Recruiting
- Liver Cirrhosis
- +6 more
- Growth Hormone
-
Chandigarh, UT, IndiaPostgraduate Institute of Medical education and Research
Mar 26, 2022